Pfizer plans to share the findings at a scientific conference and publish them in a peer-reviewed scientific journal. The company will also submit the data to regulatory agencies for review.
Source link
Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness
63Views
Stock-market investors are getting nervous about this bond-market move that’s only happened twice in over 40 years
Stock-market investors are turning jittery over something which has apparently happened only two times in the bond market since the...
What happens if you don’t pay a medical bill, now that medical debt may not hurt your credit score?
Unpaid medical debt will no longer affect credit scores, according to a new rule from Biden administration regulators who want...
Is any amount of alcohol safe to drink, in light of surgeon general’s cancer warning?
Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a warning about cancer risk. Source...
Oil prices on track for solid weekly gains, buoyed by China policy support
Oil futures were edging higher on Friday, on track for solid gains in a holiday-shortened week, buoyed by expectations of...
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact
Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang. Source link...